££......Osmetech ......Smell the Success.....££

Cricket Mad,
I think we are seeing some of it now, the OMH share price is still too low at the moment and is mainly a valuation for OPTI division. If and when we get FDA approval I expect to see some upward movement in the shareprice (how far I don't know, 30p seemed a good target earlier, but if we start from much closer to 30p we may be able to break through that level and rise higher). The important thing with this FDA approval, is that it will be the first for the platform, other approvals for CF screening and CYP450 should be easier, as the platform technology has already been accepted for approval. Also with approval the eSensor units can then be sold/leased to hospitals and then the future Assays can, on approval, be used on these units.
So I believe we should see significant upside from here, with of course some dips as well, but the share price will now be chasing the Company's achievements rather than dictating to the Company.
IMHO,DYOR,

Trout.